Time taken from primary care referral to a specialist centre diagnosis of idiopathic pulmonary fibrosis: an opportunity to improve patient outcomes?

…, T Wallis, M Casey, L Fox, K Pontopiddan… - ERJ Open …, 2020 - Eur Respiratory Soc
The care of patients with idiopathic pulmonary fibrosis (IPF) has been transformed by the
widespread approval of antifibrotic therapies [1]. Within primary care-based healthcare systems…

New perspectives on difficult asthma; sex and age of asthma-onset based phenotypes

…, Y Thirlwall, M Harvey, C Barber, K Pontoppidan… - The Journal of Allergy …, 2020 - Elsevier
Background Asthma is a diverse condition that differs with age and sex. However, it remains
unclear how sex, age of asthma onset, and/or their interaction influence clinical expression …

Prognostic imaging biomarker discovery in survival analysis for idiopathic pulmonary fibrosis

…, CJ Brereton, HW Van Es, K Pontoppidan… - … Conference on Medical …, 2022 - Springer
Imaging biomarkers derived from medical images play an important role in diagnosis, prognosis,
and therapy response assessment. Developing prognostic imaging biomarkers which …

[HTML][HTML] Pleuroparenchymal fibroelastosis in idiopathic pulmonary fibrosis: Survival analysis using visual and computer-based computed tomography assessment

…, CJ Brereton, HW Van Es, O Unat, K Pontoppidan… - …, 2021 - thelancet.com
Background Idiopathic pulmonary fibrosis (IPF) and pleuroparenchymal fibroelastosis (PPFE)
are known to have poor outcomes but detailed examinations of prognostic significance of …

Mortality in combined pulmonary fibrosis and emphysema patients is determined by the sum of pulmonary fibrosis and emphysema

…, H Jo, A De Liperi, O Unat, K Pontoppidan… - ERJ open …, 2021 - Eur Respiratory Soc
Emphysema is one of the most common pulmonary comorbidities of idiopathic pulmonary
fibrosis (IPF), presenting in about one-third of IPF patients [1]. The term combined pulmonary …

Temporal progression of mediastinal lymphadenopathy in idiopathic pulmonary fibrosis

…, E Gudmundsson, K Pontoppidan… - European …, 2022 - Eur Respiratory Soc
Idiopathic pulmonary fibrosis (IPF) is a progressive fibrotic interstitial lung disease (ILD) with
limited therapeutic options and poor prognosis. [1] The average life expectancy from …

Mortality surrogates in combined pulmonary fibrosis and emphysema

…, A De Liperi, M Duncan, K Pontoppidan… - European …, 2023 - Eur Respiratory Soc
Background Idiopathic pulmonary fibrosis (IPF) with co-existent emphysema, termed
combined pulmonary fibrosis and emphysema (CPFE) may associate with reduced forced vital …

[HTML][HTML] Delineating associations of progressive pleuroparenchymal fibroelastosis in patients with pulmonary fibrosis

…, M Heightman, A Nair, K Pontoppidan… - ERJ Open …, 2023 - Eur Respiratory Soc
Background Computer quantification of baseline computed tomography (CT) radiological
pleuroparenchymal fibroelastosis (PPFE) associates with mortality in idiopathic pulmonary …

Acute dysphagia after a normal endoscopy: think outside the box

K Pontoppidan, RP Mathew, GW Moran - Clinical medicine, 2013 - rcpjournals.org
A 45-year old lady with Lynch Syndrome (also known as hereditary non-polyposis colorectal
cancer) attended the endoscopy department for an upper and lower gastrointestinal …

[PDF][PDF] Early View

…, H Jo-Helen, A De Liperi, O Unat, K Pontoppidan… - 2021 - academia.edu
… Jo@health.nsw.gov.au5 Dr Annalisa De Liperi – a.deliperi@ao-pisa.toscana.it6 Omer
Unat - omer.selim.unat@ege.edu.tr2 Dr Katarina Pontoppidan - katarinapontoppidan@gmail.…